PRKACG
cAMP-dependent protein kinase catalytic subunit gamma
Also known as: KAPCG_HUMAN, PKACg
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P22612
- Gene
- PRKACG
- Ensembl
- ENSG00000165059
- Chromosome
- 9
- Canonical length
- 351 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Microtubules,Cytokinetic bridge,Primary cilium,Basal body,Cytosol
OverviewNCBI Gene
Cyclic AMP-dependent protein kinase (PKA) consists of two catalytic subunits and a regulatory subunit dimer. This gene encodes the gamma form of its catalytic subunit. The gene is intronless and is thought to be a retrotransposon derived from the gene for the alpha form of the PKA catalytic subunit. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
351 residues, UniProt reviewed canonical sequence.
>P22612|PRKACG
1 MGNAPAKKDT EQEESVNEFL AKARGDFLYR WGNPAQNTAS SDQFERLRTL GMGSFGRVML
61 VRHQETGGHY AMKILNKQKV VKMKQVEHIL NEKRILQAID FPFLVKLQFS FKDNSYLYLV
121 MEYVPGGEMF SRLQRVGRFS EPHACFYAAQ VVLAVQYLHS LDLIHRDLKP ENLLIDQQGY
181 LQVTDFGFAK RVKGRTWTLC GTPEYLAPEI ILSKGYNKAV DWWALGVLIY EMAVGFPPFY
241 ADQPIQIYEK IVSGRVRFPS KLSSDLKHLL RSLLQVDLTK RFGNLRNGVG DIKNHKWFAT
301 TSWIAIYEKK VEAPFIPKYT GPGDASNFDD YEEEELRISI NEKCAKEFSE FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRKACG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- testis: 23 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
Single-cell type
- late spermatids: 120 nCPM
- late primary spermatocytes: 119 nCPM
- early spermatids: 72 nCPM
- early primary spermatocytes: 5.1 nCPM
- differentiating spermatogonia: 1.7 nCPM
- peritubular myoid cells: 0.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 0.3 nTPM
- choroid plexus: 0.2 nTPM
- midbrain: 0.2 nTPM
- cerebral cortex: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- amygdala: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRKACG.
Disease | AllUniProt
Conditions PRKACG is implicated in, by any mechanism.
- Bleeding disorder, platelet-type, 19 (BDPLT19) MIM:616176
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- -0.18
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- high-density lipoprotein particle assembly
- male gonad development
- positive regulation of insulin secretion
- renal water homeostasis
- spermatogenesis
- vascular endothelial cell response to laminar fluid shear stress
Molecular functions
- ATP binding
- cAMP-dependent protein kinase activity
- potassium channel inhibitor activity
- protein kinase A regulatory subunit binding
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRKACG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRKACG as an antibody target. Whether an autoantibody or antibody against PRKACG could matter depends on whether native PRKACG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRKACG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRKACG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...